VIATRIS INC reported first-quarter revenue of $3.52 billion and adjusted profit of 59 cents per share, beating estimates of $3.36 billion and 50 cents. Shares rose 3% in afternoon trading following the results, which showed revenue growth of 8% from a year ago. Strong demand in China and branded drug sales are stabilizing the base business against manufacturing and generic competition pressures.
Viatris tops quarterly estimates on strong China growth
The drugmaker reported first-quarter revenue of 3.52 billion dollars and adjusted profit of 59 cents per share. Growth was driven by strong demand in China.
Xurve View
洞察:
Xurve View











